BLAST - Overview: Blastomyces Antibody, Enzyme Immunoassay, Serum
Aiding in the diagnosis of blastomycosis
BART - Overview: Bartonella Antibody Panel, IgG and IgM, Serum
Diagnosis of Bartonella infection, especially in the context of a cat scratch
BFBL - Overview: Bilirubin, Body Fluid
Evaluating peritoneal fluid or abdominal drain fluid as a screening test for bile leakage May aid in the distinction between a transudative and an exudative pleural effusion
C5DCU - Overview: C5-DC Acylcarnitine, Quantitative, Random, Urine
Evaluation of patients with an abnormal newborn screen showing elevations of glutarylcarnitine Diagnosis of glutaric aciduria type 1 deficiency
CD5 - Overview: CD5 Immunostain, Technical Component Only
Marker of T-cell lineage Phenotyping B-cell lymphomas
CD30 - Overview: CD30 Immunostain, Technical Component Only
Identification of CD30 expression in a variety of neoplasms
CAIX - Overview: Carbonic Anhydrase IX (CA-IX) Immunostain, Technical Component Only
Diagnosis of clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma
CD11C - Overview: CD11c Immunostain, Technical Component Only
Aiding in the diagnosis of hematological malignancies and identification of cells of the macrophage/dendritic cell lineage within tissues
CD123 - Overview: CD123 Immunostain, Technical Component Only
Marker of plasmacytoid monocytes, mast cells, and megakaryocytes
PGM1 - Overview: CD68 (PG-M1) Immunostain, Technical Component Only
Identification of monocytic differentiation Phenotyping hematolymphoid neoplasms that are suspected to represent histiocytic sarcomas
CHRO - Overview: Chromogranin Immunostain, Technical Component Only
Aiding in the identification of tumors with neuroendocrine differentiation
PIK3B - Overview: Cell-Free DNA PIK3CA Test, Blood
Identification of hormone receptor positive and human epidermal growth factor receptor 2 negative (HR+/HER2-) advanced breast cancer tumors that may be eligible for treatment with targeted kinase inhibitor therapy (eg, alpelisib).
CARF - Overview: Carbamazepine, Free, Serum
Monitoring unbound or free carbamazepine levels in patients where the total carbamazepine result is within the therapeutic range, but the patient is experiencing side effects Monitoring carbamazepine (free) therapy in patients who are...
CEAPC - Overview: Carcinoembryonic Antigen (CEA), Pancreatic Cyst Fluid
When used in conjunction with imaging studies, cytology, and other pancreatic cyst fluid tumor markers: -Distinguishing between mucinous and nonmucinous pancreatic cysts -Determining the likely type of malignant pancreatic cyst
HSCRP - Overview: C-Reactive Protein, High Sensitivity, Serum
Assessment of risk of developing myocardial infarction in patients presenting with acute coronary syndromes Assessment of risk of developing cardiovascular disease or ischemic events in individuals who do not manifest disease at present
DESG3 - Overview: Desmoglein 3 (DSG3) Immunostain, Technical Component Only
Classification of squamous cell carcinomas
DESMN - Overview: Desmin Immunostain, Technical Component Only
Identification of striated and smooth muscle cells and tumors derived from this cell type
EBNA2 - Overview: Epstein Barr Nuclear Antigen 2 (EBNA2) Immunostain, Technical Component Only
Identification of Epstein Barr virus infection in normal, inflammatory, and neoplastic tissues
HEPTP - Overview: Heparin Anti-Xa, Plasma
Measuring heparin concentration: -In patients treated with low-molecular-weight heparin preparations -In the presence of prolonged baseline activated partial thromboplastin time (APTT) (eg, lupus anticoagulant, "contact factor" deficiency,...
HEMMF - Overview: Hematologic Specified FISH, Varies
The detection of specific chromosomal abnormalities in hematologic malignancies
HMNA - Overview: Heavy Metals, Nails
Detection of nonacute arsenic, mercury, and lead exposure
HE4 - Overview: Human Epididymis Protein 4, Serum
Aiding in monitoring patients with treated epithelial ovarian cancer for recurrence or progression This test should not be used as a screening test for ovarian cancer.
Determining class II human leukocyte antigens (HLA) to identify potential disease associations or markers for drug hypersensitivity
Determining class I human leukocyte antigens (HLA) on specimens for those patients who have become refractory to platelet transfusions and identify potential disease associations or markers for drug hypersensitivity
GATA3 - Overview: GATA Binding Protein 3 Immunostain, Technical Component Only
Characterizing carcinomas, including primary bladder and breast carcinomas, and some types of mesenchymal and neuroectodermal tumors
GLUCG - Overview: Glucagon Immunostain, Technical Component Only
Aiding in the study of islet-cell tumors and some endocrine tumors of the gastrointestinal tract
Reporting an end titer result in spinal fluid specimens Distinguishing, in spinal fluid, autoimmune GFAP astrocytopathy from infectious meningoencephalitis and idiopathic inflammatory central nervous system (CNS) disorders such as multiple...
Reporting an end titer result in serum specimens Distinguishing autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy from infectious meningoencephalitis and idiopathic inflammatory central nervous system (CNS) disorders such as...
EMAI - Overview: Epithelial Membrane Antigen (EMA) Immunostain, Technical Component Only
Recognizing epithelial derivation of poorly differentiated malignant tumors Subtyping intraductal papillary mucinous neoplasms when used in conjunction with mucin (MUC) 2, MUC5AC and MUC6
IGGI - Overview: IgG Immunostain, Technical Component Only
Classification of lymphomas and multiple myeloma
IGG4I - Overview: IgG4 Immunostain, Technical Component Only
Identification of IgG4-positive plasma cells in the tissue of patients with systemic autoimmune or allergic manifestations
KRT20 - Overview: Keratin 20 (KRT20) Immunostain, Technical Component Only
Aids in determining the primary site in carcinomas of unknown origin
KRTAE - Overview: Keratin (AE1/AE3) Immunostain, Technical Component Only
Identification of cells expressing a broad spectrum of cytokeratins (low and high molecular weight keratins)
KRT5 - Overview: Keratin 5 (KRT5) Immunostain, Technical Component Only
Differentiation of mesothelioma and squamous cell carcinoma versus adenocarcinoma
Aiding in the diagnosis of multiple sclerosis and other central nervous system inflammatory conditions as a part of a profile
IA2 - Overview: Islet Antigen 2 (IA-2) Antibody, Serum
Clinical distinction of type 1 from type 2 diabetes mellitus Identification of individuals at risk of type 1 diabetes (including high-risk relatives of patients with diabetes) Prediction of future need for insulin treatment in...
INSUL - Overview: Insulin Immunostain, Technical Component Only
Identification of normal pancreatic islet beta cells and insulin secreting islet cell tumors
IGMI - Overview: IgM Immunostain, Technical Component Only
Classification of lymphomas and multiple myeloma
INHIB - Overview: Inhibin Immunostain, Technical Component Only
Identifying sex cord-stromal tumors
UIOD - Overview: Iodine, 24 Hour, Urine
Assessing iodine toxicity or recent exposure in a 24-hour urine collection Monitoring iodine excretion rate as index of replacement therapy
LYSOZ - Overview: Lysozyme Immunostain, Technical Component Only
Aiding in confirmation of monocytic and histiocytic differentiation
MYOGE - Overview: Myogenin Immunostain, Technical Component Only
Marker of skeletal muscle differentiation
CSMRT - Overview: mSMART Plasma Cell Proliferative Disorder, Pre-Analysis Cell Sorting, Bone Marrow
Risk stratification of patients with multiple myeloma, which can assist in determining treatment and management decisions Sorting plasma cells for fluorescence in situ hybridization analysis Risk stratification of patients with newly...
NKX3 - Overview: NKX3.1 Immunostain, Technical Component Only
Identifying tumors of prostatic origin
NF2F - Overview: Neurofilament (2F11) Immunostain, Technical Component Only
Aiding in the identification of neoplastic cells of neural origin or those exhibiting neuronal differentiation
FRAG - Overview: Osmotic Fragility, Erythrocytes
Evaluating suspected hereditary spherocytosis-associated hemolytic anemia Confirming or detecting mild spherocytosis
MESOP - Overview: Mesothelioma Panel (WT1/KRT5/TTF1/pCEA) Immunostain, Technical Component Only
Differentiation of mesothelioma and non-small cell lung cancer
SGSS - Overview: Synthetic Glucocorticoid Screen, Serum
Confirming the presence of listed synthetic glucocorticoids (see Interpretation) Confirming the cause of secondary adrenal insufficiency This test is not useful for detection of fluticasone propionate.
S100 - Overview: S-100 Immunostain, Technical Component Only
Aids in the identification of various neoplasms
SOX10 - Overview: SOX10 Immunostain, Technical Component Only
Identification of malignant melanomas
rights reserved. 07/2021 Hepatitis E: Testing Algorithm for Diagnosis and Management Immunocompetent patients with abnormal liver enzyme levels and at risk for hepatitis E virus (HEV) Immun......
LABORATORY IMPROVEMENT AMENDMENTS I LABORATORYNAME�R::::E OF ACCREDITAT.�10� "( CUA ID NUMBER ;• MAYO CLINIC AZ/MAYO CLINIC SCOTTSDALE 03D0530313 e 13400 EAST SHEA BOULEVARD � SCOTTSD......
mdazl-rhode-island-certification.pdf
<'.) -e >t1 .,. ... ';.� +"'" ¾liNT 0� State of Rhode Island DEPARTMENT OF HEALTH Center for Health Facilities Regulation This is to certify that MAYO CLINIC MOLECULAR DIAGNOSTICS AZ 13400 E SHEA...
Algorithms - Mayo Clinic Laboratories
A B C D E F G H I J K
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 19 - Insights
This week’s Research Roundup highlights the association of apolipoprotein E ε4 with transactive response DNA-binding protein 43....